Elicio Therapeutics
ELTX----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Elicio Therapeutics(ELTX) predict that the EBIT is -10.6 M (+1.25%), Miss estimate;the EPS is -0.65 (+25.29%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.01B1.25%
-0.01B19.05%
-0.00B17.80%
EPSMiss expectations
-0.6525.29%
-0.46546.55%
-0.185021.26%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf